Cannabis Executive Compensation 2026: What Real Operators Actually Pay GMs, CFOs, and VPs
This post reports patterns we have observed across the 50+ cannabis operators we work with and the 6 cannabis M&A integrations we have led. It is not published survey data or investment advice. Compensation varies by market, license type, operator size, and role scope. Verify with your CFO, employment counsel, and a cannabis-specialized compensation partner before restructuring executive pay.
An operator at $8 million in revenue with 42 employees across Massachusetts and New York called us last month with a single question: “what should our general manager make?” We have been asked that hundreds of times across 50+ operators. Every operator making the decision has almost no data to reference because nobody in the cannabis HR space publishes real compensation data. This post fixes that.
Cannabis executive compensation is not standard executive comp with a marijuana leaf on it. 280E blows up the tax math on senior roles. Cannabis equity is worth less than public-market equity. Multi-state operators pay differently than single-state. Retention math is worse because cannabis exec turnover runs 2 to 3 times higher than traditional consumer packaged goods. What follows is the real number range, from someone who has actually seen the numbers.
Why cannabis executive compensation is different
Five structural features separate cannabis exec comp from adjacent industries.
280E disallowance changes the entire tax math
Under IRS Section 280E, plant-touching cannabis businesses cannot deduct ordinary business expenses on federal tax returns. That includes executive compensation for anyone not directly involved in cost of goods sold. In practice, CEO, CFO, and CMO compensation is not federally tax-deductible for cannabis operators. Pay your CEO $250,000 in base salary, and the true cost lands closer to $337,000 once the federal disallowance is factored in at roughly 35 percent. This changes how you structure comp packages, not just how you size them.
Cannabis equity is worth less than public-market equity
Cannabis stock does not trade on major U.S. exchanges because of Schedule I status. Liquidity is constrained, exit windows are narrow, and MSO valuation cycles have compressed since 2022. What that means for exec comp: a $200,000 equity grant in a cannabis operator is not worth $200,000 in current dollars. Vesting structures, cliff dates, and phantom equity alternatives all need to compensate for the discount.
Multi-state, badging, and regulatory scrutiny add real premiums
Executives running two or more states have to know multiple state regulatory frameworks. Comp bands typically run 15 to 30 percent above single-state equivalents. Some states require C-suite roles to hold state cannabis agent badges (see the Massachusetts CCC agent registration framework), which limits the candidate pool and drives premiums further. Cannabis executives also face state cannabis control commission review during ownership changes and senior hires, and that risk factor shows up in the number.
The three stages of cannabis operator (with comp implications)
Cannabis exec comp bands scale with operator stage. Three archetypes cover most of what we see across 50+ operators.
Single-state pre-scale operator: $1M to $5M revenue, 10 to 30 employees, one license. Modest base salaries, minimal bonus structures, negligible equity in most cases.
Multi-state growth operator: $5M to $25M revenue, 30 to 100 employees, 2 to 5 licenses. Comp bands widen substantially. Bonuses become meaningful. Equity starts to matter for retention.
MSO or roll-up operator: $25M+ revenue, 100+ employees, 5+ licenses. Executive comp approaches publicly-traded CPG territory. Equity components can be material even with cannabis liquidity discounts.
Cannabis General Manager and operations compensation
Cannabis GM comp bands by stage. Single-state pre-scale operator: $75,000 to $110,000 base, 10 to 15 percent target bonus, minimal equity. Multi-state growth operator: $110,000 to $150,000 base, 15 to 25 percent bonus, some equity component. MSO or roll-up: $150,000 to $200,000+ base, 25 to 40 percent bonus, meaningful equity. Add a 5 to 15 percent state-license premium where the state requires the GM to hold a badged position.
VP Operations or Operations Manager overseeing multiple sites tracks similar bands with a 10 to 20 percent premium over single-site GMs. Multi-site VPs in MSOs regularly clear $200,000 base.
Cannabis cultivation and compliance leadership
Cultivation Director or Head Grower is one of the most premium roles in cannabis. Master grower talent pool is limited, and cultivation operations rely heavily on the head grower’s judgment. Ranges run $120,000 to $250,000 depending on canopy size and state, with high-yield outdoor and craft indoor operations often paying at the top of the band.
VP Compliance or Chief Compliance Officer is the highest-demand role in cannabis right now. Multi-state operators with New York, New Jersey, California, and Illinois exposure compete for candidates who can navigate all four state frameworks. Ranges run $95,000 to $180,000. Cannabis-experienced compliance leaders with multi-state track records command the top of the band, and the market has not fully caught up to demand.
Cannabis CFO compensation (and the 280E hit)
Cannabis CFO comp runs $150,000 to $300,000 base plus meaningful bonus and equity components. Cannabis-experienced CFOs command a 30 to 50 percent premium over generalist CFOs with similar operational tenure, because 280E, MSO consolidation accounting, and cannabis banking constraints are not skills you learn on the job in six months.
The 280E CFO comp trap: because CFO comp is not deductible under 280E, a $250,000 base salary carries roughly $87,500 in disallowed federal tax cost on top of the salary itself. Effective cost to the operator lands closer to $337,000. Operators structure around this by pushing part of the CFO’s scope into COGS-eligible activities (inventory oversight, plant-touching operational supervision) where legally supportable, though the SEC and IRS review of executive comp disclosure remains a constraint. See SEC executive compensation disclosure guidance for the reporting side.
Why cannabis operators should not hire an in-house Chief People Officer or VP HR
The industry range for a cannabis Chief People Officer or VP HR runs $130,000 to $250,000 depending on stage. But we do not recommend hiring one in-house at any stage of operator. The reasons are the same reasons we lay out in our cannabis HR from day one framework. In-house HR carries three structural problems that never go away as an operator scales: it costs more than fractional at every scale, employees do not trust HR that reports to their boss, and it reads as biased in wrongful termination and EEOC investigations.
Practically, this means the cannabis CPO comp band is a benchmark for what operators would spend if they hired in-house, not a recommendation. External fractional HR and fractional CHRO arrangements cover the same scope at meaningfully lower total cost. Operators who reallocate the CPO budget into growth headcount and fractional coverage typically extract more value from the same spend.
Cannabis CMO compensation
Cannabis CMO comp runs $130,000 to $260,000 with meaningful equity in growth-stage operators. Two structural constraints on the role affect the number. First, cannabis marketing is severely restricted by mainstream platforms: SEO carries cannabis penalties, Meta bans cannabis ads, Google Ads restricts, most email platforms decline cannabis mailings, and paid social is patchwork at best. Second, cannabis CMO effectiveness is measured through channels that generalist CMOs have not mastered. A cannabis-experienced CMO who has actually driven revenue through the constrained channel mix carries a real premium.
Cannabis CEO compensation
Founder CEOs are often on modest base salaries with meaningful equity, because their upside is the exit. Non-founder cannabis CEOs typically run $200,000 to $500,000+ base with meaningful bonus and equity components. MSO CEO comp frequently involves phantom equity or profits interests rather than straight cash, both to preserve cash and to align long-term incentives with an eventual liquidity event.
The 280E disallowance hits hardest at the CEO level because base salaries are highest. Sophisticated operators structure part of CEO compensation through deferred plans, split rollover equity, and profits interests to soften the tax bite. Basic operators pay straight base and eat the disallowance. See our cannabis M&A HR playbook for the executive comp side of transaction integration.
Cannabis executive equity: structures and dilution
Common cannabis executive equity structures include options with 4-year vesting and a 1-year cliff, restricted stock units with similar vesting, phantom equity for tax and reporting simplicity, and profits interests for LLCs. Dilution norms across the operators we work with: founding team retains 60 to 80 percent, employee option pool sits at 10 to 20 percent, executive grants typically fall between 0.25 percent and 2 percent depending on stage and seniority. First operator hire and CFO typically get the largest single grants outside the founding team.
Liquidity is the constant issue. No public market exists for most cannabis stock. Even MSOs that trade on the CSE face compressed valuations and limited float. Executive equity in cannabis carries a discount to headline value that ranges from 30 to 60 percent depending on operator stage and market cycle.
The retention math for cannabis executives
Cannabis executive turnover runs 2 to 3 times higher than traditional CPG based on Zen Den’s observation data. Median cannabis GM tenure is 18 to 24 months. Traditional retail GM tenure is 4 to 5 years. The cost of losing a cannabis GM lands between $50,000 and $150,000 in recruiting fees, productivity loss, and revenue impact during the transition. Turnover at the CFO and CMO layer is similarly elevated, with departures often clustering around fundraising cycles and M&A activity.
Comp is one retention lever. Culture, career pathing, equity clarity, and manager quality matter more. Operators who solve the non-comp levers first see 30 to 50 percent longer executive tenure. Operators who only pull the comp lever end up in a bidding war they cannot win.
The mistake most operators make
The single most common cannabis executive comp mistake we see: paying generalist market rate without the cannabis premium. An operator hires a GM at $110,000 (traditional retail GM band) and loses them 14 months later to a competitor paying $140,000 (cannabis-adjusted band). The operator spent $110,000 for 14 months of tenure and lost a further $50,000+ replacing them. Meanwhile the competitor got 3 to 4 years of tenure on the $140,000 investment.
The fix: pay 15 to 25 percent above generalist comp for the cannabis-specific role, tie a piece of comp to retention with a 2-year vesting cliff and 3-year deferred component, and layer state-license premium where applicable. Multi-state operators should also cross-reference our multi-state cannabis HR playbook for the state-by-state comp adjustments.
What to do this week if you are hiring an executive
Five moves this week.
First, pull the comp band above for your role and your operator stage. Second, add the cannabis premium (15 to 25 percent) above the generalist equivalent. Third, design retention comp with deferred components, equity, and cliff vesting; a signing bonus that pays out day 1 disappears by day 2. Fourth, model the 280E disallowance so you know your true cost, particularly for non-COGS roles (CEO, CFO, CMO). Fifth, compare your target comp against your comp philosophy: are you paying to attract, to retain, or to minimize cost? Pick one; you cannot optimize for all three simultaneously.
If you want an outside set of eyes on a specific executive hire or comp band decision, book a 15-minute call. We run comp band analysis for operators as part of every engagement and can pattern-match your specific hire against the 50+ operator observation base within a single call. See our cannabis HR services triggers for when to reach out.
Frequently asked questions about cannabis executive compensation
Role-specific comp questions
Cannabis GM base salary ranges from $75,000 to $200,000 depending on operator stage. Single-state pre-scale operators pay $75,000 to $110,000. Multi-state growth operators pay $110,000 to $150,000. MSOs pay $150,000 to $200,000+. Bonuses range from 10 to 40 percent of base depending on stage, and equity components appear at the multi-state stage and become meaningful at MSO scale.
IRS Section 280E disallows deductions on compensation for anyone not directly involved in cost of goods sold. CEO, CFO, and CMO comp is not federally tax-deductible for cannabis operators. A $250,000 CEO salary carries roughly $87,500 in disallowed federal tax cost, bringing effective cost to about $337,000. Operators structure around this by moving scope into COGS-eligible activities where legally supportable.
Cannabis executives command a 15 to 30 percent premium over generalist equivalents at the same operator size, especially for roles requiring cannabis-specific expertise (CFO with 280E fluency, CCO with multi-state track record, master grower with yield accountability). Total comp is often lower at MSO scale because cannabis equity carries a liquidity discount of 30 to 60 percent versus public market equity.
Executive grants outside the founding team typically fall between 0.25 percent and 2 percent depending on stage and seniority. First operator hire and CFO typically get the largest single grants. Founding team retains 60 to 80 percent, employee option pool sits at 10 to 20 percent. Cannabis equity carries a 30 to 60 percent liquidity discount to headline value, which vesting and cliff structures should compensate for.
Retention, in-house HR, and multi-state
Cannabis executive turnover runs 2 to 3 times higher than traditional CPG. Median cannabis GM tenure is 18 to 24 months versus 4 to 5 years in traditional retail. The drivers include younger operator age, fundraising volatility, MSO consolidation cycles, comp bands that generalist retail cannot match once cannabis-experienced execs are recruited by competitors, and cultural fit gaps between cannabis and adjacent industries.
No. In-house HR is never the right answer for cannabis operators at any stage. It costs more than external at every scale, employees do not trust HR that reports to their boss, and it reads as biased in wrongful termination and EEOC investigations. Cannabis operators should use fractional CHRO or fractional HR arrangements from day one, even at two employees. The industry CPO comp band ($130,000 to $250,000) is a benchmark for what operators would spend, not a recommendation to spend it.
$50,000 to $150,000 in recruiting fees, productivity loss during the vacancy, and revenue impact during the transition. Cannabis GM roles carry higher replacement cost than adjacent retail because cannabis-specialized candidate pools are smaller, state-license premiums drive comp higher on the rehire, and lost tenure typically shows up as retention drop across the retail floor.
Multi-state cannabis operators should add a 15 to 30 percent premium over single-state equivalents for executives running multiple state frameworks. Comp should reflect state-license premiums where roles require badging, retention comp should include deferred components tied to multi-state P&L milestones, and comp bands should be reviewed against every operating state annually. Multi-state operators are also the highest-exposure cluster for wrongful termination and wage claims, which factors into total cost.
Editor's note
This post is informational and reflects patterns we have seen across the 50+ cannabis operators we work with. It is not legal advice. Federal drug testing, DOT compliance, and immigration rules interact in complicated ways and change frequently. Consult licensed employment counsel and immigration counsel before making hire or fire decisions involving federally-regulated workers.
July 29, 2026
Kim Bruen
Be the first to comment